These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 21418261

  • 21. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE.
    Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
    [Abstract] [Full Text] [Related]

  • 22. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J, OBIS Study Investigators.
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [Abstract] [Full Text] [Related]

  • 23. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 24. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome.
    Tsuchiya J, Barreto R, Okura R, Kawakita S, Fesce E, Marotta F.
    Chin J Dig Dis; 2004 Aug 15; 5(4):169-74. PubMed ID: 15612887
    [Abstract] [Full Text] [Related]

  • 25. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC, Croffut RM, Stranahan MC.
    Clin Ther; 2005 Jun 15; 27(6):755-61. PubMed ID: 16117982
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
    Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM.
    Am J Gastroenterol; 2006 Jul 15; 101(7):1581-90. PubMed ID: 16863564
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 15; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 28. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM.
    Aliment Pharmacol Ther; 2009 Jan 15; 29(1):97-103. PubMed ID: 18785988
    [Abstract] [Full Text] [Related]

  • 29. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):463-73. PubMed ID: 17635381
    [Abstract] [Full Text] [Related]

  • 30. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):994-1002. PubMed ID: 18671775
    [Abstract] [Full Text] [Related]

  • 31. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
    Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.
    Am J Gastroenterol; 2007 Aug 15; 102(8):1709-19. PubMed ID: 17509028
    [Abstract] [Full Text] [Related]

  • 32. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K, Korpela R.
    Asia Pac J Clin Nutr; 2006 Aug 15; 15(4):576-80. PubMed ID: 17077079
    [Abstract] [Full Text] [Related]

  • 33. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
    Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R.
    Scand J Gastroenterol; 2011 Jun 15; 46(6):663-72. PubMed ID: 21443416
    [Abstract] [Full Text] [Related]

  • 34. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A.
    J Clin Gastroenterol; 2017 Jan 15; 51(1):e5-e10. PubMed ID: 27306945
    [Abstract] [Full Text] [Related]

  • 35. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF, Miner PB, Fischer L, Harris MS.
    Aliment Pharmacol Ther; 2011 Oct 15; 34(8):868-77. PubMed ID: 21883322
    [Abstract] [Full Text] [Related]

  • 36. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
    Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D, Symbiotic Study Group.
    Minerva Gastroenterol Dietol; 2006 Dec 15; 52(4):349-58. PubMed ID: 17108864
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 38. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR.
    Neurogastroenterol Motil; 2005 Oct 14; 17(5):687-96. PubMed ID: 16185307
    [Abstract] [Full Text] [Related]

  • 39. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.
    Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B.
    Nutrients; 2020 Jul 05; 12(7):. PubMed ID: 32635661
    [Abstract] [Full Text] [Related]

  • 40. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, Scholz M, Tuohy KM, Lindsay JO, Irving PM, Whelan K.
    Gastroenterology; 2017 Oct 05; 153(4):936-947. PubMed ID: 28625832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.